The investment fund Stratus SCP Brasil Coinvestimento II (Stratus) acquired 100% of Investfarma S.A., a company that controls the pharmacy chain Poupafarma, as well as other related companies.
Stratus would have bought all the companies that make up Investfarma, in a series of operations approved by the Administrative Council of Economic Defense (CADE).
In October 2018, CADE approved the acquisition of Farma Participacoes, arguing that competition would not be affected by these incursions, considering Stratus’ participation in other sectors such as gyms, collection companies and private transportation.
Full Content: LexLatin
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
CMA Fines Tereos £25,000 for Failing to Provide Key Information in Merger Probe
Sep 27, 2024 by
CPI
Google Defends Its Role in Online Advertising Market in Antitrust Trial
Sep 27, 2024 by
CPI
Musk’s X Requests Brazil Supreme Court to Resume Service After Shutdown
Sep 26, 2024 by
CPI
Visa Acquires AI Firm Featurespace to Enhance Fraud Prevention
Sep 26, 2024 by
CPI
Visa Gears Up for Legal Fight with DOJ Over Debit Card Monopoly Allegations
Sep 26, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Refusal to Deal
Sep 27, 2024 by
CPI
Antitrust’s Refusal-to-Deal Doctrine: The Emperor Has No Clothes
Sep 27, 2024 by
Erik Hovenkamp
Why All Antitrust Claims are Refusal to Deal Claims and What that Means for Policy
Sep 27, 2024 by
Ramsi Woodcock
The Aspen Misadventure
Sep 27, 2024 by
Roger Blair & Holly P. Stidham
Refusal to Deal in Antitrust Law: Evolving Jurisprudence and Business Justifications in the Align Technology Case
Sep 27, 2024 by
Timothy Hsieh